AR021751A1 - Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas - Google Patents

Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas

Info

Publication number
AR021751A1
AR021751A1 ARP990103922A ARP990103922A AR021751A1 AR 021751 A1 AR021751 A1 AR 021751A1 AR P990103922 A ARP990103922 A AR P990103922A AR P990103922 A ARP990103922 A AR P990103922A AR 021751 A1 AR021751 A1 AR 021751A1
Authority
AR
Argentina
Prior art keywords
alkyl
different
alkyloxy
group
substituted
Prior art date
Application number
ARP990103922A
Other languages
English (en)
Spanish (es)
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of AR021751A1 publication Critical patent/AR021751A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ARP990103922A 1998-08-05 1999-08-05 Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas AR021751A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998FI000186A IT1304888B1 (it) 1998-08-05 1998-08-05 Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono

Publications (1)

Publication Number Publication Date
AR021751A1 true AR021751A1 (es) 2002-08-07

Family

ID=11352646

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103922A AR021751A1 (es) 1998-08-05 1999-08-05 Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas

Country Status (11)

Country Link
EP (1) EP1102789A1 (it)
JP (1) JP2002522450A (it)
AR (1) AR021751A1 (it)
AU (1) AU5507999A (it)
CA (1) CA2339638A1 (it)
CO (1) CO5080789A1 (it)
IT (1) IT1304888B1 (it)
PE (1) PE20001002A1 (it)
TR (1) TR200100354T2 (it)
TW (1) TW491857B (it)
WO (1) WO2000008046A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1622569B1 (en) 2003-04-24 2015-12-02 Incyte Corporation Aza spiro alkane derivatives as inhibitors of metallproteases
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703034A (en) * 1986-04-28 1987-10-27 Merck & Co., Inc. Novel cyclic tetrapeptide
JPH06509571A (ja) * 1991-08-08 1994-10-27 エイ・メナリニ・インダストリー・ファーマシューティケ・リウニテ・エスアールエル タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物
ES2103857T3 (es) * 1991-08-13 1997-10-01 Takeda Chemical Industries Ltd Peptidos ciclicos y su uso.
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista

Also Published As

Publication number Publication date
CO5080789A1 (es) 2001-09-25
AU5507999A (en) 2000-02-28
JP2002522450A (ja) 2002-07-23
CA2339638A1 (en) 2000-02-17
IT1304888B1 (it) 2001-04-05
PE20001002A1 (es) 2000-10-16
TR200100354T2 (tr) 2001-05-21
EP1102789A1 (en) 2001-05-30
ITFI980186A1 (it) 2000-02-05
TW491857B (en) 2002-06-21
WO2000008046A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
RU2203272C2 (ru) Замещенные бициклические соединения, исходные и промежуточные продукты для их получения и фармацевтическая композиция на их основе
UY27322A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
AR055878A1 (es) Derivados de ciclopropanocarboxamida
ES2185665T3 (es) Derivados de benzofurano como antagonistas de taquicininas.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
PE20030431A1 (es) DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7
EA200970704A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТАГОНИСТЫ NK1 РЕЦЕПТОРА И БЛОКАТОРЫ Na КАНАЛОВ
DK0505377T3 (da) Muscarinreceptorantagonister
UY27336A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
AR009938A1 (es) Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos
ES2127919T3 (es) 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos.
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
EA200970705A1 (ru) Новые фармацевтические композиции
PE20060457A1 (es) Derivados de difenil eter como antagonistas de los receptores 5ht2
YU53100A (sh) Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
ES2059873T3 (es) 2-alquinilfenoles sustituidos con actividad antiinflamatoria, un procedimiento para su preparacion y sus composiciones farmaceuticas.
UY24429A1 (es) Acetidinas
AR021751A1 (es) Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas
ES2045126T3 (es) Agentes terapeuticos.
PE20030611A1 (es) Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones
AR065208A1 (es) Derivados de tetrahidronaftaleno sustituidos con heterociclos o sus analogos bencilsustituidos, metodo de preparacion, medicamentos que los contienen y usos de los mismos, como ligandos de receptores 5-ht7, en patologias asociadas al snc, entre otras.
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.
AR022797A1 (es) Benzoil indoles n-sustituidos como agentes estrogenicos
ES2161892T3 (es) Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1.